After the post-Golgi stage, tyrosinase might be degraded in proteasomes via post-translation modification in the ER, as has been reported in linoleic acid treated melanoma cells33 and/or it could be degraded via the endosomal/lysosomal degradation system, as reported in inulavosin-treated melanoma cells34. This evidence concerns the gene TYR and melanoma.